[go: up one dir, main page]

WO1999053288A3 - Logiciel interpretatif de l'immunoblot de lyme - Google Patents

Logiciel interpretatif de l'immunoblot de lyme Download PDF

Info

Publication number
WO1999053288A3
WO1999053288A3 PCT/US1999/008160 US9908160W WO9953288A3 WO 1999053288 A3 WO1999053288 A3 WO 1999053288A3 US 9908160 W US9908160 W US 9908160W WO 9953288 A3 WO9953288 A3 WO 9953288A3
Authority
WO
WIPO (PCT)
Prior art keywords
employed
interpreting
methods
systems
interpretation
Prior art date
Application number
PCT/US1999/008160
Other languages
English (en)
Other versions
WO1999053288A9 (fr
WO1999053288A2 (fr
Inventor
Andrew E Levin
A Scott Oddo
Original Assignee
Immunetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunetics Inc filed Critical Immunetics Inc
Priority to AU36428/99A priority Critical patent/AU3642899A/en
Publication of WO1999053288A2 publication Critical patent/WO1999053288A2/fr
Publication of WO1999053288A9 publication Critical patent/WO1999053288A9/fr
Publication of WO1999053288A3 publication Critical patent/WO1999053288A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Analysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Image Processing (AREA)

Abstract

On décrit des systèmes et des procédés automatisés pouvant être mis en oeuvre pour interpréter des immunoblots de Lyme. Ces programmes peuvent analyser les motifs en bandes produits par immunotransfert ('Western Blot test', par exemple), par numérisation de la membrane d'essai effectuée avec une caméra numérique, et par interprétation des résultats d'analyse (positifs ou négatifs). Selon le cas, on utilise soit une analyse statistique de données de bande, soit un ordinateur neuronal. Le programme statistique peut incorporer des algorithmes interprétatifs, tels que ceux reconnus par CDC/ASTPHLD pour les immunoblots de Lyme. L'ordinateur neuronal est doué de capacités d'apprentissage qui lui permettent d'améliorer ses performances et de mettre au point ses propres critères d'interprétation grâce à l'analyse d'un grand nombre d'échantillons positifs ou négatifs.
PCT/US1999/008160 1998-04-14 1999-04-14 Logiciel interpretatif de l'immunoblot de lyme WO1999053288A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36428/99A AU3642899A (en) 1998-04-14 1999-04-14 Systems and methods for interpreting immunoblot test results

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8167998P 1998-04-14 1998-04-14
US60/081,679 1998-04-14

Publications (3)

Publication Number Publication Date
WO1999053288A2 WO1999053288A2 (fr) 1999-10-21
WO1999053288A9 WO1999053288A9 (fr) 1999-12-02
WO1999053288A3 true WO1999053288A3 (fr) 2000-04-13

Family

ID=22165689

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/008160 WO1999053288A2 (fr) 1998-04-14 1999-04-14 Logiciel interpretatif de l'immunoblot de lyme

Country Status (2)

Country Link
AU (1) AU3642899A (fr)
WO (1) WO1999053288A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104115478B (zh) * 2011-12-16 2016-04-20 利-考股份有限公司 发光成像扫描仪
EP2989446B1 (fr) * 2013-04-24 2018-10-03 Euroimmun Medizinische Labordiagnostika AG Procédé d'évaluation automatique des bandelettes des immunoblots incubeés
DE102013008468A1 (de) 2013-05-21 2014-11-27 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur automatisierten Auswertung von inkubierten lmmunoblotstreifen
WO2020082029A1 (fr) * 2018-10-18 2020-04-23 The Regents Of The University Of California Dispositif et système de test sérodiagnostic pour la maladie de lyme à un stade précoce à l'aide d'un dosage immunologique multiplexé
ES3036240T3 (en) 2019-11-25 2025-09-17 Hoffmann La Roche Method of determining a concentration of an analyte in a bodily fluid
WO2022076516A1 (fr) * 2020-10-09 2022-04-14 The Trustees Of Columbia University In The City Of New York Interprétation automatisée adaptable de tests diagnostiques rapides à l'aide d'un apprentissage auto-supervisé et d'un apprentissage en quelques coups

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281517A (en) * 1985-11-04 1994-01-25 Cell Analysis Systems, Inc. Methods for immunoploidy analysis
EP0637744A1 (fr) * 1993-06-11 1995-02-08 Ortho Diagnostic Systems, Inc. Méthode et dispositif pour classifier des réactions d'agglutination
US5585276A (en) * 1991-05-10 1996-12-17 Wisconsin Alumni Research Foundation Medium and method for blotting macromolecules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281517A (en) * 1985-11-04 1994-01-25 Cell Analysis Systems, Inc. Methods for immunoploidy analysis
US5585276A (en) * 1991-05-10 1996-12-17 Wisconsin Alumni Research Foundation Medium and method for blotting macromolecules
EP0637744A1 (fr) * 1993-06-11 1995-02-08 Ortho Diagnostic Systems, Inc. Méthode et dispositif pour classifier des réactions d'agglutination

Also Published As

Publication number Publication date
WO1999053288A9 (fr) 1999-12-02
AU3642899A (en) 1999-11-01
WO1999053288A2 (fr) 1999-10-21

Similar Documents

Publication Publication Date Title
Gray et al. Objective selection of sensitive species indicative of pollution-induced change in benthic communities. I. Comparative methodology
DK1151300T3 (da) Assay til påvisning af en bindingspartner
ATE118892T1 (de) Testträger für die analyse einer probenflüssigkeit, verfahren zur durchführung einer solchen analyse und herstellungsverfahren.
EP1376651A3 (fr) Méthode et dispositif d' analyse des données en spectrométrie de masse
CA2220388A1 (fr) Procede et dispositif permettant d'evaluer la qualite de la preparation de lames et d'echantillons
WO2002067188A3 (fr) Analyse d'images du complexe de golgi
PT1078256E (pt) Processo para avaliar ensaios quimicos e biologicos
WO1999053288A3 (fr) Logiciel interpretatif de l'immunoblot de lyme
WO2004083901A3 (fr) Detection de macro-defauts a l'aide d'entrees de micro-inspection
EP1623352A4 (fr) Procedes computationnels et systemes d'analyse multidimensionnelle
Maki Evaluation of Toxicant Effects on Structure and Function of Model Stream Communities: Correlations With Natural Stream Effects.
WO2005024594A3 (fr) Methodes d'utilisation et de programmation d'un instrument d'analyse
WO1999063320A3 (fr) Systeme informatique et procede informatise d'analyse des resultats de tests cytologiques en vue d'une evaluation du rendement des cytologistes
Abend On-line qualification of test facilities, using statistical methods
Weiss et al. The Speech Enhancement Advanced Development Model.
WO2002021132A3 (fr) Essais relatifs aux cellules
McKinley et al. A Voice Communication Effectiveness Test
Sharp et al. Determining the pitch period of speech using no multiplications
CN116223440A (zh) 一种烟叶原料配比的近红外检测装置
Berndt Design of a water quality monitoring network
FR2854994B1 (fr) Dispositif et procede de rejection d'interferences auto-adaptatif
Goode Adaptive sensor array processing.
Dammann An experiment in cluster detection
Schmidt-Nielsen et al. Dual Task Performance with LPC (Linear Predictive Coding) Degraded Speech in a Sentence Verification Task
King System Testing Techniques for Computer Networks

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/6-6/6, DRAWINGS, REPLACED BY NEW PAGES 1/6-6/6; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase